You are here
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
SBC: MARINE1 LLC Topic: SOCOM10005
Marine 1, LLC and senior business partner Moxahela Enterprises, LLC are pleased to present this proposal for the US Special Operations Command (USSOCOM) Small Business Innovative Research (SBIR) topic number SOCOM10-005 for high speed combatant craft automated ride control. USSOCOM has identified the need for a lightweight, automated ride control system that will model and predict craft motion to ...SBIR Phase I 2010 Department of DefenseSpecial Operations Command
SBC: UES INC Topic: SOCOM10006
The Special Operations Forces mission requirement for remote weather sensing can be satisfied with an innovative solution that addresses tactical mobility in high threat environments. Within this context UES proposes the development of a novel Micro Weather Sensor, a modular system consisting of a comprehensive sensor suite and a compact, powerful networking device. The suite measures temperatur ...SBIR Phase I 2010 Department of DefenseSpecial Operations Command
SBC: Nico Technologies Corp. Topic: CBD10103
The drug R&D cycle is long and very expensive. In many ways, this status quo can no longer be sustained. One of the reasons for such great cost is that the vast majority of drug candidates are screened out at the stages of animal and human trials. More efficient methods of testing of drugs at the stage of ex-vivo studies, which are substantially less expensive than animal and human testing cyc ...SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense
SBC: CFD RESEARCH CORPORATION Topic: CBD10103
Current drug discovery and development programs are severely limited by the expensive animal trials and oversimplified in vitro models. Results obtained from the in vitro models are not predictive of in vivo toxicity owing to significant difference in testing from the in vivo physiological conditions. In this context, we propose to develop and demonstrate a novel microfluidic device for quantitati ...SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense
SBC: CFD RESEARCH CORPORATION Topic: CBD10107
Molecular biology techniques allow generating combinatorial libraries of large number of enzyme variants. However, there is currently no technology available for screening the enzyme libraries for identifying variants with improved activity for the substrate. We propose to develop a novel, microfluidic, high-throughput platform for determining kinetic constants of enzyme variants and identifying v ...SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense
SBC: Aqua Resources Corporation Topic: SOCOM10007
The dynamics of nano-size interactions of metal hydroxide nanoplatelets is a new field of material science. Initial research conducted by Aqua Resources and the Department of Defense, offers the promise of an innovative means of effectively defending against Chemical/Biological (CB) warfare agents in a cost effective manner without the attendant residues and long-term damage associated with tradit ...SBIR Phase I 2010 Department of DefenseSpecial Operations Command